These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 3378253)

  • 1. [Iproplatin--advantages and disadvantages of a new platinum cytostatic agent].
    Hejl J; Hejlová N
    Cas Lek Cesk; 1988 Apr; 127(15):467-70. PubMed ID: 3378253
    [No Abstract]   [Full Text] [Related]  

  • 2. [Carboplatin--a new platinum cytostatic].
    Hejl J; Hejlová N; Mechl Z; Pípalová I; Jurásková V
    Cas Lek Cesk; 1985 Jul; 124(29):917-8. PubMed ID: 3899362
    [No Abstract]   [Full Text] [Related]  

  • 3. Platinum compounds.
    Belani CP; Van Echo DA; Aisner J
    Curr Opin Oncol; 1989 Dec; 1(2):186-91. PubMed ID: 2489958
    [No Abstract]   [Full Text] [Related]  

  • 4. [Second generation of antitumor complex platinum compounds in experimental and clinical chemotherapy].
    Presnov MA; Konovalova AL; Gorbunova VA
    Vestn Akad Med Nauk SSSR; 1986; (12):79-89. PubMed ID: 3548147
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical development of iproplatin (CHIP).
    Creaven PJ; Pendyala L; Madajewicz S
    Drugs Exp Clin Res; 1986; 12(1-3):287-92. PubMed ID: 3732051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activity and distribution studies of five platinum analogues in nude mice bearing human ovarian carcinoma xenografts.
    Boven E; van der Vijgh WJ; Nauta MM; Schlüper HM; Pinedo HM
    Cancer Res; 1985 Jan; 45(1):86-90. PubMed ID: 4038381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of patients with intestinal cancer. Increased neurotoxicity after oxaliplatin and related liver metastasis].
    Junker A; Kretzschmar A; Böhm U; Tannapfel A; Langenbahn D; Pieck AC; Jaehde U
    Med Monatsschr Pharm; 2004 Oct; 27(10):349-52. PubMed ID: 15527179
    [No Abstract]   [Full Text] [Related]  

  • 8. New drug approved for colorectal cancer.
    FDA Consum; 2002; 36(5):2. PubMed ID: 12412532
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo studies of a platinum(II) metallointercalator.
    Fisher DM; Fenton RR; Aldrich-Wright JR
    Chem Commun (Camb); 2008 Nov; (43):5613-5. PubMed ID: 18997969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Platinum complexes in cancer pharmacy. Individual patient cytostatic preparation].
    Warnke U
    Pharm Unserer Zeit; 2006; 35(2):110-6. PubMed ID: 16583564
    [No Abstract]   [Full Text] [Related]  

  • 11. Phase II study of iproplatin (CHIP) in patients with cisplatin-refractory germ cell tumors; the need for alternative strategies in the investigation of new agents in GCT.
    Murphy BA; Motzer RJ; Bosl GJ
    Invest New Drugs; 1992 Nov; 10(4):327-30. PubMed ID: 1336770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Satraplatin: an orally available platinum analog for the treatment of cancer.
    Choy H
    Expert Rev Anticancer Ther; 2006 Jul; 6(7):973-82. PubMed ID: 16831070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxaliplatin in colorectal cancer: an overview.
    Armand JP; Boige V; Raymond E; Fizazi K; Faivre S; Ducreux M
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):96-104. PubMed ID: 11049040
    [No Abstract]   [Full Text] [Related]  

  • 14. Agents ameliorating or augmenting the nephrotoxicity of cisplatin and other platinum compounds: a review of some recent research.
    Ali BH; Al Moundhri MS
    Food Chem Toxicol; 2006 Aug; 44(8):1173-83. PubMed ID: 16530908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin-induced Evan's syndrome.
    Earle CC; Chen WY; Ryan DP; Mayer RJ
    Br J Cancer; 2001 Feb; 84(3):441. PubMed ID: 11161414
    [No Abstract]   [Full Text] [Related]  

  • 16. Oxaliplatin-based chemotherapy in the management of colorectal cancer.
    Capdevila J; Elez E; Peralta S; Macarulla T; Ramos FJ; Tabernero J
    Expert Rev Anticancer Ther; 2008 Aug; 8(8):1223-36. PubMed ID: 18699761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of platinol analogs using the M5076 murine sarcoma.
    Rose WC
    Anticancer Res; 1986; 6(4):557-62. PubMed ID: 3530116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Platinum complexes as potential antineoplastic drugs].
    Kuduk-Jaworska J
    Postepy Hig Med Dosw; 1984; 38(3):281-322. PubMed ID: 6398870
    [No Abstract]   [Full Text] [Related]  

  • 19. Limited activity of carboplatin in malignant lymphoma.
    Danieu L; Warrell RP
    Cancer Treat Rep; 1986 Jul; 70(7):931-2. PubMed ID: 3521851
    [No Abstract]   [Full Text] [Related]  

  • 20. Phase II study of oxaliplatin in platinum-resistant and refractory ovarian cancer: a gynecologic group study.
    Fracasso PM; Blessing JA; Morgan MA; Sood AK; Hoffman JS
    J Clin Oncol; 2003 Aug; 21(15):2856-9. PubMed ID: 12885801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.